The disparity in phosphorylation observed in diabetes suggests that conformational changes within the Cx43 CT, or its interaction with other binding partners, may block the ability of PKC-ε to efficiently phosphorylate Cx43 at S368 in the setting of the non-insulin-treated diabetic heart. This evidence concerns the gene INS and diabetes mellitus.